XP Inc. heads into its August 17 report carrying a narrative under strain. Last quarter, management insisted that credit-spread widening and softer net new money were external shocks rather than signs of a broken growth engine. This report is the first real chance to prove that framing correct, and the stakes are higher than they might appear given the stock's recent slide.

Wall Street currently models EPS of $0.51 on revenue of $976.5 million, which would represent roughly 18.5% year-over-year revenue growth, an acceleration from the 8% pace XP posted last quarter and a return closer to the double-digit growth trajectory management has repeatedly promised for the full year. The Earnings Whisper of $0.53 sits modestly above consensus, suggesting some traders expect a clean beat, though the gap is not dramatic enough to signal outsized optimism. Sequentially, EPS of $0.51 would mark healthy improvement from the $0.47 posted in the prior quarter, and comparing to the $0.43 earned in the same quarter last year shows the kind of steady compounding investors have grown accustomed to from XP, at least on the bottom line.

The more interesting story sits beneath the headline numbers. Last quarter's call revealed a business with real crosscurrents. Equity revenue was genuinely accelerating, climbing to about R$1.2 billion and now representing 31% of gross revenue, while the corporate and wholesale franchise kept stepping higher each quarter. But those bright spots were offset by margin compression, with EBT margin slipping to 30% and the efficiency ratio drifting to a multi-year high, along with a sharp drop in net new money to R$14 billion from R$32 billion the prior quarter. Management attributed the fixed-income weakness to March and April credit-spread widening and said compression should not materially reverse until the back half of the year, meaning this quarter is unlikely to fully resolve that issue but should show whether the damage is stabilizing rather than deepening.

That sets up several concrete checkpoints. Did equity revenue and corporate segment growth continue their upward march, reinforcing that XP's diversification strategy is genuinely working rather than just cushioning a slowing core? Did net new money recover meaningfully from the R$14 billion trough, particularly on the corporate and institutional side, which actually went negative last quarter? And did the efficiency ratio and ROE, which have been sliding for three consecutive quarters, finally stabilize, or is elevated capital combined with margin pressure becoming a more structural issue rather than a one-quarter blip?

The market's verdict since the last report has been unforgiving. XP shares have fallen 3.7% while the S&P 500 gained 5.9%, a nearly 10 percentage point gap that suggests investors are not yet willing to take management's transient framing at face value. The stock trades at $15.84, well below its 200-day moving average of $18.10, and sits closer to the low end of its post-earnings range of $14.80 to $18.36 rather than testing a breakout. Sentiment has improved from deeply negative levels three months ago, now sitting just barely positive, which suggests expectations have reset lower rather than turned euphoric.

The central question is whether this quarter shows the fixed-income and inflow weakness fading as management predicted, or whether the pressures that emerged last quarter are proving stickier than the transient narrative suggested. A rebound in net new money and stabilizing margins would go a long way toward restoring confidence that XP's double-digit growth guidance remains intact.